Kestra Medical Technologies, Ltd.
KMTS
$25.15
-$0.07-0.26%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.57M | 19.37M | 17.23M | 15.09M | 14.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.57M | 19.37M | 17.23M | 15.09M | 14.71M |
| Cost of Revenue | 11.14M | 10.52M | 9.60M | 8.54M | 8.88M |
| Gross Profit | 11.42M | 8.85M | 7.63M | 6.55M | 5.83M |
| SG&A Expenses | 38.30M | 33.73M | 50.46M | 23.80M | 21.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.32M | 48.25M | 65.45M | 35.69M | 33.84M |
| Operating Income | -31.76M | -28.88M | -48.21M | -20.60M | -19.13M |
| Income Before Tax | -32.75M | -25.79M | -51.01M | -21.74M | -20.61M |
| Income Tax Expenses | 34.00K | 33.00K | 102.00K | 18.00K | 8.00K |
| Earnings from Continuing Operations | -32.79M | -25.83M | -51.11M | -21.76M | -20.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -942.00K | 250.00K | 253.00K |
| Net Income | -32.79M | -25.83M | -52.05M | -21.51M | -20.37M |
| EBIT | -31.76M | -28.88M | -48.21M | -20.60M | -19.13M |
| EBITDA | -29.38M | -26.85M | -46.38M | -18.71M | -17.27M |
| EPS Basic | -0.64 | -0.50 | -2.25 | -1.25 | -1.19 |
| Normalized Basic EPS | -0.40 | -0.31 | -1.34 | -0.67 | -0.64 |
| EPS Diluted | -0.64 | -0.50 | -2.25 | -1.25 | -1.19 |
| Normalized Diluted EPS | -0.40 | -0.31 | -1.34 | -0.67 | -0.64 |
| Average Basic Shares Outstanding | 51.38M | 51.30M | 24.58M | 19.89M | 19.89M |
| Average Diluted Shares Outstanding | 51.38M | 51.30M | 24.58M | 19.89M | 19.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |